Renaissance Technologies
BLTE

Renaissance Technologies’s Belite Bio BLTE Stock Holding History

Renaissance Technologies’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.59M Buy
55,763
+3,763
+7% +$577K 0.01% 1145
2026
Q1 		$8.29M Buy
+52,000
New +$8.74M 0.01% 1069
2025
Q4 		– Sell
-2,812
Closed -$208K – 3261
2025
Q3 		$208K Sell
2,812
-1,488
-35% -$97.7K ﹤0.01% 3125
2025
Q2 		$248K Buy
+4,300
New +$262K ﹤0.01% 3099
2024
Q1 		– Sell
-4,900
Closed -$224K – 3712
2023
Q4 		$224K Buy
+4,900
New +$188K ﹤0.01% 3093

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies's BLTE Position: Q2 2026 in Review

Renaissance Technologies increased its Belite Bio (BLTE) stake by 7.2% in Q2 2026, buying an estimated $577K and bringing the position to 55,763 shares worth $8.59M. The position accounts for 0.01% of the portfolio, ranked #1145.

Renaissance Technologies first reported a position in BLTE in Q4 2023 and has held it in 5 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Renaissance Technologies held 55,763 shares of Belite Bio worth $8.59M as of Q2 2026.
  • Renaissance Technologies bought 3,763 Belite Bio shares in Q2 2026, an estimated $577K.
  • Belite Bio made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1145 holding.
  • Renaissance Technologies first reported a position in Belite Bio in Q4 2023 and has held it in 5 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.